Literature DB >> 10080445

Assessment of restrictive cardiomyopathy of amyloid or idiopathic etiology by magnetic resonance imaging.

F Celletti1, R Fattori, G Napoli, O Leone, G Rocchi, L B Reggiani, G Gavelli.   

Abstract

This study was designed to assess the role of magnetic resonance imaging in the differential diagnosis of amyloid and idiopathic etiology of cardiomyopathy. This technique demonstrated the capability to differentiate the 2 forms, providing high-resolution evaluation of the myocardial wall and detecting the infiltrative pathology by tissue characterization.

Entities:  

Mesh：

Year:  1999        PMID： 10080445     DOI： 10.1016/s0002-9149(98)00998-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  5 in total

Review 1.  MR, CT, and PET imaging in pericardial disease.

Authors:  Peter Alter; Jens H Figiel; Thomas P Rupp; Georg F Bachmann; Bernhard Maisch; Marga B Rominger
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

2.  Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis.

Authors:  Ralf Wassmuth; Hassan Abdel-Aty; Steffen Bohl; Jeanette Schulz-Menger
Journal:  Eur Radiol       Date:  2011-03-29       Impact factor: 5.315

Review 3.  The emerging role of MRI in the diagnosis and management of cardiomyopathies.

Authors:  Carlos Eduardo Rochitte; Eduardo Marinho Tassi; Afonso Akio Shiozaki
Journal:  Curr Cardiol Rep       Date:  2006-02       Impact factor: 2.931

4.  Utility of the inversion scout sequence (TI scout) in diagnosing myocardial amyloid infiltration.

Authors:  Tarun Pandey; Kedar Jambhekar; Raja Shaikh; Shelly Lensing; Sanjaya Viswamitra
Journal:  Int J Cardiovasc Imaging       Date:  2012-04-22       Impact factor: 2.357

5.  Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis.

Authors:  Frederick L Ruberg; Evan Appelbaum; Ravin Davidoff; Al Ozonoff; Kraig V Kissinger; Caitlin Harrigan; Martha Skinner; Warren J Manning
Journal:  Am J Cardiol       Date:  2008-12-25       Impact factor: 2.778
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.